pirenzepine has been researched along with Migraine Disorders in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silberstein, SD | 1 |
| Peres, MF | 1 |
| Hopkins, MM | 1 |
| Shechter, AL | 1 |
| Young, WB | 1 |
| Rozen, TD | 1 |
1 other study available for pirenzepine and Migraine Disorders
| Article | Year |
|---|---|
Olanzapine in the treatment of refractory migraine and chronic daily headache.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Female; Headache Disorders; Humans; Male; Mi | 2002 |